Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 9 of 9 entries
View as:

Assess the Efficacy and Safety of Multi-target Therapy in Lupus Nephritis

Phase: N/A Priority: Normal
NCT ID: NCT00876616 Org: User:
Start: 04/30/09 End: 02/29/12 Due: 02/28/13

The Clinical Efficacy of DFPP in Patients With AAGN

Phase: N/A Priority: Normal
NCT ID: NCT02294344 Org: User:
Start: 06/30/14 End: 04/30/17 Due: 04/30/18

Long-Term Study of Multi-target Therapy as Maintenance Treatment for Lupus Nephritis

Phase: N/A Priority: Normal
NCT ID: NCT01056237 Org: User:
Start: 02/28/10 End: 06/30/13 Due: 06/30/14

Bortezomib for Immunoglobulin Light Chain(AL) Amyloidosis

Phase: N/A Priority: Normal
NCT ID: NCT02485613 Org: User:
Start: 01/31/09 End: 03/31/15 Due: 03/31/16

A Prospective, Single-center, Randomized, Controlled Study of Sevelamer Carbonate in the Lipid Metabolism and Uric Acid Treatment of Obesity-Related Glomerulopathy

Phase: N/A Priority: Normal
NCT ID: NCT02644486 Org: User:
Start: 01/31/16 End: 02/28/18 Due: 02/28/19

An Multi-site Prospective Study to Assess the Efficacy and Safety of MMF in the Treatment of Proliferative IgA Nephropathy(IgAN)

Phase: N/A Priority: Normal
NCT ID: NCT01269021 Org: User:
Start: 11/30/10 End: 04/30/14 Due: 04/30/15

Study of Bortezomib +HSCT in Primary Systemic Amyloidosis (AL)

Phase: N/A Priority: Normal
NCT ID: NCT01273844 Org: User:
Start: 03/01/11 End: 05/12/16 Due: 05/12/17

Randomized Clinical Trial of Triptolide Woldifii for Autosomal Dominant Polycystic Kidney Disease

Phase: N/A Priority: Normal
NCT ID: NCT00801268 Org: User:
Start: 11/30/08 End: 11/30/13 Due: 11/30/14

Treatment of Idiopathic Membranous Nephropathy With Tripterygium Wilfordii Plus Steroid vs Tacrolimus Plus Steroid

Phase: N/A Priority: Normal
NCT ID: NCT01161459 Org: User:
Start: 06/30/10 End: 10/31/13 Due: 10/31/14